YONGLIYONG LI15165LI, YONGProfessorprns:coAuthorOfcoauthor ofprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:grantAwardedBygrant awarded byprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provinceAgreementvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofRolevivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonExperimental TherapeuticsHematopathologyLeukemiaLymphoma-MyelomaMolecular & Cellular OncologyMD AndersonMIEN-CHIEHUNGMIEN-CHIE HUNG8427HUNG, MIEN-CHIEProfessorKEN HEYOUNGKEN HE YOUNG9713YOUNG, KEN HEProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorFREDRICK BHAGEMEISTERFREDRICK B HAGEMEISTER8570HAGEMEISTER, FREDRICK BProfessorL JEFFREYMEDEIROSL JEFFREY MEDEIROS8762MEDEIROS, L JEFFREYProfessorGEORGE ACALINGEORGE A CALIN9408CALIN, GEORGE AProfessor74Professor10Assistant Professor54InstructorZIJUNXU-MONETTEZIJUN XU-MONETTE11821XU-MONETTE, ZIJUNInstructorMedicine-Epidemiology & Populat SciD000951Chemicals & Drugs50015010.601033Antigens, NeoplasmD054875Phenomena2775750.79419UbiquitinationD019496Chemicals & Drugs2336960.647037Cancer VaccinesD019139Disorders1462510.838137Tumor EscapeDepartment of MedicineMedicine-General MedicineBaylor College of MedicineD063646Disorders49310250.613428Carcinogenesis31127191Miao Y, Medeiros LJ, Li Y, Li J, Young KHNature reviews. Clinical oncologyGenetic alterations and their clinical implications in DLBCL. Nat Rev Clin Oncol. 2019 10; 16(10):634-652.Nat Rev Clin Oncol2019-10-01T00:00:002019Genetic alterations and their clinical implications in DLBCL.31277689Wang L, Deng Q, Hu H, Liu M, Gong Z, Zhang S, Xu-Monette ZY, Lu Z, Young KH, Ma X, Li YJournal of hematology & oncologyGlyphosate induces benign monoclonal gammopathy and promotes multiple myeloma progression in mice. J Hematol Oncol. 2019 07 05; 12(1):70.J Hematol Oncol2019-07-05T00:00:002019Glyphosate induces benign monoclonal gammopathy and promotes multiple myeloma progression in mice.31640780Xu-Monette ZY, Li J, Xia Y, Crossley B, Bremel RD, Miao Y, Xiao M, Snyder T, Manyam GC, Tan X, Zhang H, Visco C, Tzankov A, Dybkaer K, Bhagat G, Tam W, You H, Hsi ED, van Krieken JH, Huh J, Ponzoni M, Ferreri AJM, M?ller MB, Piris MA, Winter JN, Medeiros JT, Xu B, Li Y, Kirsch I, Young KHJournal for immunotherapy of cancerImmunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies. J Immunother Cancer. 2019 10 22; 7(1):272.J Immunother Cancer2019-10-22T00:00:002019Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies.One Baylor PlazaHouston, 77030TX1.305250.00949323202research areas3.752540.045784219coauthor of46.341910.102260similar to1151selected publicationsXINFANGYUXINFANG YU15215YU, XINFANGInstructor31699989Deng Q, Hu H, Yu X, Liu S, Wang L, Chen W, Zhang C, Zeng Z, Cao Y, Xu-Monette ZY, Li L, Zhang M, Rosenfeld S, Bao S, Hsi E, Young KH, Lu Z, Li YNature communicationsTissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant. Nat Commun. 2019 11 07; 10(1):5061.Nat Commun2019-11-07T00:00:002019Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant.71Postdoc Fellows and AssociatesPostDoc32357935Yu X, Li W, Liu H, Deng Q, Wang X, Hu H, Xu-Monette ZY, Xiong W, Lu Z, Young KH, Wang W, Li YJournal of hematology & oncologyUbiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation. J Hematol Oncol. 2020 05 01; 13(1):40.J Hematol Oncol2020-05-01T00:00:002020Ubiquitination of the DNA-damage checkpoint kinase CHK1 by TRAF4 is required for CHK1 activation.32366834Zhou H, Xu-Monette ZY, Xiao L, Strati P, Hagemeister FB, He Y, Chen H, Li Y, Manyam GC, Li Y, Montes-Moreno S, Piris MA, Young KHBlood cancer journalPrognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up. Blood Cancer J. 2020 05 04; 10(5):49.Blood Cancer J2020-05-04T00:00:002020Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up.32521648Sobhani N, D'Angelo A, Wang X, Young KH, Generali D, Li YInternational journal of molecular sciencesMutant p53 as an Antigen in Cancer Immunotherapy. Int J Mol Sci. 2020 Jun 08; 21(11).Int J Mol Sci2020-06-08T00:00:002020Mutant p53 as an Antigen in Cancer Immunotherapy.32722783Xu-Monette ZY, Zhang H, Zhu F, Tzankov A, Bhagat G, Visco C, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, You H, Huh J, Ponzoni M, Ferreri AJM, M?ller MB, Parsons BM, van Krieken JH, Piris MA, Winter JN, Hagemeister FB, Shahbaba B, De Dios I, Zhang H, Li Y, Xu B, Albitar M, Young KHBlood advancesA refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL. Blood Adv. 2020 07 28; 4(14):3391-3404.Blood Adv2020-07-28T00:00:002020A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL.32756356Flores-Villanueva P, Sobhani N, Wang X, Li YCancersMR1-Restricted T Cells in Cancer Immunotherapy. Cancers (Basel). 2020 Aug 03; 12(8).Cancers (Basel)2020-08-03T00:00:002020MR1-Restricted T Cells in Cancer Immunotherapy.32792499Liu M, Wang X, Li W, Yu X, Flores-Villanueva P, Xu-Monette ZY, Li L, Zhang M, Young KH, Ma X, Li YOncogenesisTargeting PD-L1 in non-small cell lung cancer using CAR T cells. Oncogenesis. 2020 Aug 13; 9(8):72.Oncogenesis2020-08-13T00:00:002020Targeting PD-L1 in non-small cell lung cancer using CAR T cells.33025009Yu X, Li W, Deng Q, Liu H, Wang X, Hu H, Cao Y, Xu-Monette ZY, Li L, Zhang M, Lu Z, Young KH, Li YBloodMYD88 L265P elicits mutation-specific ubiquitination to drive NF-?B activation and lymphomagenesis. Blood. 2021 03 25; 137(12):1615-1627.Blood2021-03-25T00:00:002021MYD88 L265P elicits mutation-specific ubiquitination to drive NF-?B activation and lymphomagenesis.33148342Deng M, Zhang M, Xu-Monette ZY, Pham LV, Tzankov A, Visco C, Fang X, Bhagat G, Zhu F, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, Choi WWL, Huh J, Ponzoni M, Ferreri AJM, M?ller MB, Parsons BM, van Krieken JH, Piris MA, Winter JN, Hagemeister F, Alinari L, Li Y, Andreeff M, Xu B, Young KHJournal of hematology & oncologyXPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53. J Hematol Oncol. 2020 11 04; 13(1):148.J Hematol Oncol2020-11-04T00:00:002020XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53.33154093Deng M, Xu-Monette ZY, Pham LV, Wang X, Tzankov A, Fang X, Zhu F, Visco C, Bhagat G, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, You H, Huh J, Ponzoni M, Ferreri AJM, M?ller MB, Parsons BM, Hagemeister F, van Krieken JH, Piris MA, Winter JN, Li Y, Xu B, Liu P, Young KHMolecular cancer research : MCRAggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents. Mol Cancer Res. 2021 02; 19(2):249-260.Mol Cancer Res2020-11-05T00:00:002020Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents.33234576Schaafsma E, Zhao Y, Zhang L, Li Y, Cheng CMolecular cancer research : MCRMYC Activity Inference Captures Diverse Mechanisms of Aberrant MYC Pathway Activation in Human Cancers. Mol Cancer Res. 2021 03; 19(3):414-428.Mol Cancer Res2020-11-24T00:00:002020MYC Activity Inference Captures Diverse Mechanisms of Aberrant MYC Pathway Activation in Human Cancers.true1Postdoc Fellows and AssociatesPostdoc Fellows and AssociatesPraveen KumarNeeliPraveen Kumar Neeli16380Neeli, Praveen KumarPostdoc Fellows and Associates33735664Wang Y, Gali VL, Xu-Monette ZY, Sano D, Thomas SK, Weber DM, Zhu F, Fang X, Deng M, Zhang M, Hagemeister FB, Li Y, Orlowski RZ, Lee HC, Young KHNeoplasia (New York, N.Y.)Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenstr?m macroglobulinemia. Neoplasia. 2021 04; 23(4):361-374.Neoplasia2021-03-15T00:00:002021Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenstr?m macroglobulinemia.33809974Sobhani N, Tardiel-Cyril DR, Davtyan A, Generali D, Roudi R, Li YCancersCTLA-4 in Regulatory T Cells for Cancer Immunotherapy. Cancers (Basel). 2021 Mar 22; 13(6).Cancers (Basel)2021-03-22T00:00:002021CTLA-4 in Regulatory T Cells for Cancer Immunotherapy.33910064Fan C, Qu H, Wang X, Sobhani N, Wang L, Liu S, Xiong W, Zeng Z, Li YSeminars in cancer biologyCancer/testis antigens: from serology to mRNA cancer vaccine. Semin Cancer Biol. 2021 11; 76:218-231.Semin Cancer Biol2021-04-25T00:00:002021Cancer/testis antigens: from serology to mRNA cancer vaccine.Authorship 101853913Authorship 101854014Authorship 10185419Authorship 101854214Authorship 10185439Authorship 101854414Authorship 101854511Authorship 10185466Authorship 101854714Authorship 101854817Authorship 10185494Authorship 101855016Authorship 10185518Authorship 101855210Authorship 101855319Authorship 10185549Authorship 101855511Authorship 10185564Authorship 101855722Authorship 10185586Authorship 101855910Authorship 101856015Authorship 101856112Authorship 101856215Authorship 10185635Authorship 10185649Authorship 101856510Authorship 101856618Authorship 101856718Authorship 101856825Authorship 10185709Authorship 101857112Authorship 101857213Authorship 10185733Authorship 101857411Authorship 101857522Authorship 101857623Authorship 10185771233999309Xiong F, Zhu K, Deng S, Huang H, Yang L, Gong Z, Shi L, He Y, Tang Y, Liao Q, Yu J, Li X, Li Y, Li G, Zeng Z, Xiong W, Zhang S, Guo CScience China. Life sciencesAFAP1-AS1: a rising star among oncogenic long non-coding RNAs. Sci China Life Sci. 2021 Oct; 64(10):1602-1611.Sci China Life Sci2021-05-13T00:00:002021AFAP1-AS1: a rising star among oncogenic long non-coding RNAs.33975628Li L, Xiong F, Wang Y, Zhang S, Gong Z, Li X, He Y, Shi L, Wang F, Liao Q, Xiang B, Zhou M, Li X, Li Y, Li G, Zeng Z, Xiong W, Guo CJournal of experimental & clinical cancer research : CRWhat are the applications of single-cell RNA sequencing in cancer research: a systematic review. J Exp Clin Cancer Res. 2021 May 11; 40(1):163.J Exp Clin Cancer Res2021-05-11T00:00:002021What are the applications of single-cell RNA sequencing in cancer research: a systematic review.33951538Wang M, Dai M, Wang D, Tang T, Xiong F, Xiang B, Zhou M, Li X, Li Y, Xiong W, Li G, Zeng Z, Guo CCancer lettersThe long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway. Cancer Lett. 2021 08 01; 512:60-72.Cancer Lett2021-05-02T00:00:002021The long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway.33926508Tan F, Zhao M, Xiong F, Wang Y, Zhang S, Gong Z, Li X, He Y, Shi L, Wang F, Xiang B, Zhou M, Li X, Li Y, Li G, Zeng Z, Xiong W, Guo CJournal of experimental & clinical cancer research : CRN6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies. J Exp Clin Cancer Res. 2021 Apr 29; 40(1):146.J Exp Clin Cancer Res2021-04-29T00:00:002021N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies.33904341Wang Y, Mo Y, Peng M, Zhang S, Gong Z, Yan Q, Tang Y, He Y, Liao Q, Li X, Wu X, Xiang B, Zhou M, Li Y, Li G, Li X, Zeng Z, Guo C, Xiong WAutophagyThe influence of circular RNAs on autophagy and disease progression. Autophagy. 2022 02; 18(2):240-253.Autophagy2021-04-27T00:00:002021The influence of circular RNAs on autophagy and disease progression.33858374Tan Z, Zou Y, Zhu M, Luo Z, Wu T, Zheng C, Xie A, Wang H, Fang S, Liu S, Li Y, Lu ZBMC cancerCarnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer. BMC Cancer. 2021 Apr 15; 21(1):409.BMC Cancer2021-04-15T00:00:002021Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer.33648534Zhang Y, Wang D, Peng M, Tang L, Ouyang J, Xiong F, Guo C, Tang Y, Zhou Y, Liao Q, Wu X, Wang H, Yu J, Li Y, Li X, Li G, Zeng Z, Tan Y, Xiong WJournal of experimental & clinical cancer research : CRSingle-cell RNA sequencing in cancer research. J Exp Clin Cancer Res. 2021 Mar 01; 40(1):81.J Exp Clin Cancer Res2021-03-01T00:00:002021Single-cell RNA sequencing in cancer research.33397409Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, Ren D, Hua Y, Yu B, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Xiong W, Zeng ZMolecular cancerMechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer. 2021 01 04; 20(1):7.Mol Cancer2021-01-04T00:00:002021Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.33094864Wu Y, Wang D, Wei F, Xiong F, Zhang S, Gong Z, Shi L, Li X, Xiang B, Ma J, Deng H, He Y, Liao Q, Zhang W, Li X, Li Y, Guo C, Zeng Z, Li G, Xiong WFASEB journal : official publication of the Federation of American Societies for Experimental BiologyEBV-miR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1. FASEB J. 2020 12; 34(12):16205-16223.FASEB J2020-10-23T00:00:002020EBV-miR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1.32974180Dai S, Mo Y, Wang Y, Xiang B, Liao Q, Zhou M, Li X, Li Y, Xiong W, Li G, Guo C, Zeng ZFrontiers in oncologyChronic Stress Promotes Cancer Development. Front Oncol. 2020; 10:1492.Front Oncol2020-08-19T00:00:002020Chronic Stress Promotes Cancer Development.32972383Fan C, Wang J, Tang Y, Zhang S, Xiong F, Guo C, Zhou Y, Li Z, Li X, Li Y, Li G, Zeng Z, Xiong WBMC cancerUpregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers. BMC Cancer. 2020 Sep 24; 20(1):917.BMC Cancer2020-09-24T00:00:002020Upregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers.32931883Fan C, Qu H, Xiong F, Tang Y, Tang T, Zhang L, Mo Y, Li X, Guo C, Zhang S, Gong Z, Li Z, Xiang B, Deng H, Zhou M, Liao Q, Zhou Y, Li X, Li Y, Li G, Wang F, Zeng ZCancer lettersCircARHGAP12 promotes nasopharyngeal carcinoma migration and invasion via ezrin-mediated cytoskeletal remodeling. Cancer Lett. 2021 01 01; 496:41-56.Cancer Lett2020-09-12T00:00:002020CircARHGAP12 promotes nasopharyngeal carcinoma migration and invasion via ezrin-mediated cytoskeletal remodeling.32815067Fan C, Zhang S, Gong Z, Li X, Xiang B, Deng H, Zhou M, Li G, Li Y, Xiong W, Zeng Z, Li XScience China. Life sciencesEmerging role of metabolic reprogramming in tumor immune evasion and immunotherapy. Sci China Life Sci. 2021 Apr; 64(4):534-547.Sci China Life Sci2020-08-17T00:00:002020Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.32364663Tang T, Yang L, Cao Y, Wang M, Zhang S, Gong Z, Xiong F, He Y, Zhou Y, Liao Q, Xiang B, Zhou M, Guo C, Li X, Li Y, Xiong W, Li G, Zeng ZMolecular oncologyLncRNA AATBC regulates Pinin to promote metastasis in nasopharyngeal carcinoma. Mol Oncol. 2020 09; 14(9):2251-2270.Mol Oncol2020-06-13T00:00:002020LncRNA AATBC regulates Pinin to promote metastasis in nasopharyngeal carcinoma.32306460Wang D, Zeng Z, Zhang S, Xiong F, He B, Wu Y, Li W, Tang L, Wei F, Xiang B, Li Z, Zhou Y, Zhou M, Li X, Li Y, Li G, Xiong W, Guo CFASEB journal : official publication of the Federation of American Societies for Experimental BiologyEpstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis. FASEB J. 2020 06; 34(6):8012-8027.FASEB J2020-04-18T00:00:002020Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis.32188012Navid S, Fan C, O Flores-Villanueva P, Generali D, Li YInternational journal of molecular sciencesThe Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments. Int J Mol Sci. 2020 Mar 16; 21(6).Int J Mol Sci2020-03-16T00:00:002020The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments.32040694Wang D, Tang L, Wu Y, Fan C, Zhang S, Xiang B, Zhou M, Li X, Li Y, Li G, Xiong W, Zeng Z, Guo CCellular and molecular life sciences : CMLSAbnormal X chromosome inactivation and tumor development. Cell Mol Life Sci. 2020 Aug; 77(15):2949-2958.Cell Mol Life Sci2020-02-10T00:00:002020Abnormal X chromosome inactivation and tumor development.32019587Wu P, Mo Y, Peng M, Tang T, Zhong Y, Deng X, Xiong F, Guo C, Wu X, Li Y, Li X, Li G, Zeng Z, Xiong WMolecular cancerEmerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol Cancer. 2020 02 04; 19(1):22.Mol Cancer2020-02-04T00:00:002020Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA.32000802Ren D, Hua Y, Yu B, Ye X, He Z, Li C, Wang J, Mo Y, Wei X, Chen Y, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Zeng Z, Xiong WMolecular cancerPredictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy. Mol Cancer. 2020 01 30; 19(1):19.Mol Cancer2020-01-30T00:00:002020Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy.31443694Peng M, Mo Y, Wang Y, Wu P, Zhang Y, Xiong F, Guo C, Wu X, Li Y, Li X, Li G, Xiong W, Zeng ZMolecular cancerNeoantigen vaccine: an emerging tumor immunotherapy. Mol Cancer. 2019 08 23; 18(1):128.Mol Cancer2019-08-23T00:00:002019Neoantigen vaccine: an emerging tumor immunotherapy.33093911Li P, Zhang S, Mo Y, Zhang L, Wang Y, Xiong F, Zhang S, Liu J, Xu Y, Zeng Z, Xiong W, Li Y, Gong ZOncology lettersLong non-coding RNA expression profiles and related regulatory networks in areca nut chewing-induced tongue squamous cell carcinoma. Oncol Lett. 2020 Dec; 20(6):302.Oncol Lett2020-09-29T00:00:002020Long non-coding RNA expression profiles and related regulatory networks in areca nut chewing-induced tongue squamous cell carcinoma.2019-08-31NIHLI, YONG2009-04-01Convergence of MicroRNAs and p53 Signaling in Multiple Myeloma: Environmental CoR01CA1386882012-06-30NIHLI, YONG2009-09-26Role of Retroelements in Environmental AtherogenesisR01ES0172742021-03-31NIHLI, YONG2015-04-08Modulation of MicroRNAs with Xenobiotics to Target c-MycR01CA1778102012-03-31NIHLI, YONG2007-06-04Center for Environmental Genomics and Integrative BiologyP30ES0144432023-05-31NIHLI, YONG2018-06-15Dietary Carcinogens for Colorectal CancerR01CA2290802024-04-30NIHLI, YONG2018-05-10TP53 Germline Mutations: Beyond LFSR01CA2195562021-03-31NIHLI, YONG2015-04-20MYC as a Biomarker in Aggressive Non-Hodgkin LymphomaR01CA1874152017-08-31NIHLI, YONG2014-06-01MicroRNAs as Biomarkers for Tobacco Exposure and Heart DiseaseR21HL120050Principal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorPrincipal InvestigatorAuthorship 10223141734168109Zhong Y, Yang L, Xiong F, He Y, Tang Y, Shi L, Fan S, Li Z, Zhang S, Gong Z, Guo C, Liao Q, Zhou Y, Zhou M, Xiang B, Li X, Li Y, Zeng Z, Li G, Xiong WSignal transduction and targeted therapyLong non-coding RNA AFAP1-AS1 accelerates lung cancer cells migration and invasion by interacting with SNIP1 to upregulate c-Myc. Signal Transduct Target Ther. 2021 06 25; 6(1):240.Signal Transduct Target Ther2021-06-25T00:00:002021Long non-coding RNA AFAP1-AS1 accelerates lung cancer cells migration and invasion by interacting with SNIP1 to upregulate c-Myc.true1ProfessorProfessor34829931Yu X, Li W, Young KH, Li YBiomedicinesPosttranslational Modifications in PD-L1 Turnover and Function: From Cradle to Grave. Biomedicines. 2021 Nov 16; 9(11).Biomedicines2021-11-16T00:00:002021Posttranslational Modifications in PD-L1 Turnover and Function: From Cradle to Grave.34805170Zhou S, Fan C, Zeng Z, Young KH, Li YFrontiers in cell and developmental biologyClinical and Immunological Effects of p53-Targeting Vaccines. Front Cell Dev Biol. 2021; 9:762796.Front Cell Dev Biol2021-11-03T00:00:002021Clinical and Immunological Effects of p53-Targeting Vaccines.true1InstructorInstructor34980601Xu-Monette ZY, Wei L, Fang X, Au Q, Nunns H, Nagy M, Tzankov A, Zhu F, Visco C, Bhagat G, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, Hagemeister FB, Sun X, Han X, Go H, Ponzoni M, Ferreri AJM, M?ller MB, Parsons BM, van Krieken JH, Piris MA, Winter JN, Li Y, Xu B, Albitar M, You H, Young KHClinical cancer research : an official journal of the American Association for Cancer ResearchGenetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma. Clin Cancer Res. 2022 Mar 01; 28(5):972-983.Clin Cancer Res2022-03-01T00:00:002022Genetic Subtyping and Phenotypic Characterization of the Immune Microenvironment and MYC/BCL2 Double Expression Reveal Heterogeneity in Diffuse Large B-cell Lymphoma.35105854Albitar M, Zhang H, Goy A, Xu-Monette ZY, Bhagat G, Visco C, Tzankov A, Fang X, Zhu F, Dybkaer K, Chiu A, Tam W, Zu Y, Hsi ED, Hagemeister FB, Huh J, Ponzoni M, Ferreri AJM, M?ller MB, Parsons BM, van Krieken JH, Piris MA, Winter JN, Li Y, Xu B, Young KHBlood cancer journalDetermining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms. Blood Cancer J. 2022 02 01; 12(2):25.Blood Cancer J2022-02-01T00:00:002022Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms.35759856Sobhani N, Scaggiante B, Morris R, Chai D, Catalano M, Tardiel-Cyril DR, Neeli P, Roviello G, Mondani G, Li YCancer treatment reviewsTherapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials. Cancer Treat Rev. 2022 Sep; 109:102429.Cancer Treat Rev2022-06-22T00:00:002022Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials.35765110Wang X, Yu X, Li W, Neeli P, Liu M, Li L, Zhang M, Fang X, Young KH, Li YJournal of experimental & clinical cancer research : CRExpanding anti-CD38 immunotherapy for lymphoid malignancies. J Exp Clin Cancer Res. 2022 Jun 28; 41(1):210.J Exp Clin Cancer Res2022-06-28T00:00:002022Expanding anti-CD38 immunotherapy for lymphoid malignancies.JORGECASTILLOJORGE CASTILLO18140CASTILLO, JORGEAssistant Professortrue1Assistant ProfessorAssistant Professor36399513Li Y, Xu-Monette ZY, Abramson J, Sohani AR, Bhagat G, Tzankov A, Visco C, Zhang S, Dybkaer K, Pan Z, Xu M, Tam W, Zu Y, Hsi ED, Hagemeister FB, Go H, van Krieken JH, Winter JN, Ponzoni M, Ferreri AJM, M?ller MB, Piris MA, Wang Y, Zhang M, Young KHBlood advancesEBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential. Blood Adv. 2023 04 11; 7(7):1308-1311.Blood Adv2023-04-11T00:00:002023EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential.36719382Yu X, Li W, Liu H, Wang X, Coarfa C, Cheng C, Yu X, Zeng Z, Cao Y, Young KH, Li YThe Journal of clinical investigationPD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination. J Clin Invest. 2023 02 01; 133(3).J Clin Invest2023-02-01T00:00:002023PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination.37150255Cheng C, Hong W, Li Y, Xiao X, McKay J, Han Y, Byun J, Peng B, Albanes D, Lam S, Tardon A, Chen C, Bojesen SE, Landi MT, Johansson M, Risch A, Bickeb?ller H, Wichmann HE, Christiani DC, Rennert G, Arnold S, Goodman G, Field JK, Davies MPA, Shete SS, Le Marchand L, Liu G, Hung RJ, Andrew AS, Kiemeney LA, Zhu M, Shen H, Zienolddiny S, Grankvist K, Johansson M, Cox A, Hong YC, Yuan JM, Lazarus P, Schabath MB, Aldrich MC, Brennan P, Li Y, Gorlova O, Gorlov I, Amos CI, INTEGRAL-ILCCO Lung Cancer ConsortiumJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerMosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis. J Thorac Oncol. 2023 08; 18(8):1003-1016.J Thorac Oncol2023-05-05T00:00:002023Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis.Authorship 107120643Authorship 107120711Authorship 10712081Authorship 107120910Authorship 107121021Authorship 107121123Authorship 10712124Authorship 10712135Authorship 1071214Authorship 1071215Authorship 1071216Mo Y, Wang Y, Wang Y, Deng X, Yan Q, Fan C, Zhang S, Zhang S, Gong Z, Shi L, Liao Q, Guo C, Li Y, Li G, Zeng Z, Jiang W, Xiong W, Xiang Bmol cancerCircular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop. mol cancer. 2023; 21(1):192.2023-06-21T00:00:002023Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loopGarcia-Sanz R, Varettoni M, Jiménez C, Ferrero S, Poulain S, San-Miguel JF, Guerrera ML, Drandi D, Bagratuni T, McMaster M, Roccaro AM, Roos-Weil D, Leiba M, Li Y, Qiu L, Hou J, De Larrea CF, Castillo JJ, Dimopoulos M, Owen RG, Treon SP, Hunter ZRSemin HematolReport of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia. Semin Hematol. 2023; 60(2):90-96.2023-06-21T00:00:002023Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's MacroglobulinemiaGopalan V, Nilsen T, Gopalan V, Altman AM, Stark BC, Feinstein SI, Koski R, Mickiewicz C, Stark B, Gegenheimer P, Kirsebom LA, Arnez JG, Forster AC, Kazakov SA, Yuan Y, Liu F, Jarrous N, Yang L, Jiang G, Jiang T, Rosenbaum JL, Miller G, DiMaio D, Carlson JR, McClain WH, Mathews MB, Kaempfer R, Deutscher MP, Chen LL, Li Y, Wang E, Patutina O, Zenkova M, Vlassov V, Lucks JB, Gopalan VRNATribute to Sidney Altman. RNA. 2023; 28(11):1393-1429.2023-06-21T00:00:002023Tribute to Sidney AltmanAuthorship 1071251102027-08-31NIHLI, YONG2023-09-01Cancer Prevention-Interception Against MGUS ProgressionU54CA272691Principal Investigatortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1InstructorInstructortrue1ProfessorProfessortrue1ProfessorProfessor